By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dendreon Corporation 

3005 First Avenue

Seattle  Washington  98121  U.S.A.
Phone: 206-256-4545 Fax: 206-256-0571



Company News
Sanpower Group Completes The Acquisition Of Dendreon (DNDN) From Valeant (VRX) 6/29/2017 7:32:22 AM
Dendreon (DNDN) Announces New Findings Demonstrating Durable And Robust Killer T-Cell Response With PROVENGE 6/5/2017 1:55:57 PM
Dendreon (DNDN) Announces Results Of New PROCEED Registry Analysis Showing Overall Survival Benefit With PROVENGE In Men With Metastatic Prostate Cancer 5/15/2017 6:59:25 AM
Ex-Dendreon (DNDN) CEO Returns to Biotech, Throws a Lifeline to Struggling Nivalis (NVLS) 4/19/2017 5:47:10 AM
Debt-Ridden Valeant (VRX) Offloads Dendreon (DNDN) for $819.9 Million Cash 1/10/2017 5:40:22 AM
In Juno (JUNO) Patient Deaths, Echoes Seen Of Earlier Failed Company Dendreon (DNDN) 7/11/2016 8:12:35 AM
Former Dendreon (DNDN) CEO Pulls in $48 Million for Latest Startup Alpine Immune Sciences 6/13/2016 7:00:18 AM
Why Ex-Dendreon (DNDN) CEO's New Startup Could Succeed Where Dendreon Failed 3/5/2015 7:14:26 AM
Valeant (VRX) Starts Chopping Dendreon (DNDN) Employees 3/3/2015 10:53:02 AM
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences 3/3/2015 6:41:12 AM